Hypertrophic Obstructive Cardiomyopathy Clinical Trial
Official title:
Compare the Results for the Extended Myoectomy and Standard Morrow's Myoectomy in Patients With Ventricular Obstruction of the Left Ventricular Output
The purpose of this study is to determine whether the application of the extended myoectomy in patients with obstruction of the left ventricular output more efficient than standard myoectomy by Morrow.
Many years myoectomy for Morrow was the gold standard in the treatment of obstructive
hypertrophic cardiomyopathy. Currently more retrospective data in the literature about the
good results the extended septal myectomy. Use of extended myomectomy eliminates mitral
insufficiency due to SAM syndrome. The question remains whether it is possible at
hypertrophic cardiomyopathy basal part and mediated mitral insufficiency use only myoectomy
by Morrow is achieved regression SAM syndrome and release output of the left ventricle.
Planned to create two equal groups of 30 people that will use two methods of surgical
treatment of obstructive hypertrophic cardiomyopathy. The study will be terminated in the
event of complete AV block more than 2% and unsatisfactory results of a myoectomy requiring
perform mitral valve replacement in more than 15% of the patients studied. The study assumed
crossover: in case of failure elimination SAM syndrome and mediated mitral insufficiency
myoectomy by Morrow for patients will perform extended myoectomy in the case of a good
result in patients are moved to the second group.
Planned studies the long-term and immediate results of operations:
- Quantitative determination of enzymes of myocardial injury: creatine phosphokinase MB
and troponin I.
- Determination of atrial natriuretic peptide (ANP) and brain natriuretic peptide (VNP).
- MRI with contrast heart to assess remodeling of the heart chambers and heart weight
measurements.
- TEE evaluation function and mitral valve gradient at the output of the left ventricle.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05073094 -
Esmolol for Myocardial Protection in Hypertrophic Obstructive Cardiomyopathy
|
Phase 4 | |
Completed |
NCT05850026 -
Mitral Regurgitation in Hypertrophic Obstructive Cardiomyopathy: Fix it in a Simple, Effective and Durable Way!
|
||
Completed |
NCT04777188 -
Speckle Tracking Echocardiography Analysis of Left Ventricular Myocardium After Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy
|
N/A | |
Completed |
NCT02054221 -
Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy With Severe Mitral Insufficiency.
|
N/A | |
Withdrawn |
NCT04905173 -
Comparison of Squat-to-Stand Maneuver With Amyl Nitrite, Valsalva, and Exercise Stress Echocardiography in Inducing Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy
|
N/A | |
Completed |
NCT04066777 -
The Effect of TASH in Patients With HOCM
|
N/A | |
Terminated |
NCT02674958 -
Mobilization of Endothelial Progenitor Cells and Aspirin
|
Phase 3 | |
Not yet recruiting |
NCT04329689 -
Hyp Obst Cardiomyopathy
|
N/A | |
Not yet recruiting |
NCT05025644 -
Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensional Transesophageal Echocardiography Under Provocative Dobutamine Stress Test
|
Phase 4 | |
Recruiting |
NCT05257772 -
Electromechanically Optimised Right Ventricular Pacing In Hypertrophic Cardiomyopathy (EMORI-HCM)
|
N/A | |
Recruiting |
NCT04470102 -
Edge-to-edge Mitral Valve Repair in the Surgical Treatment for Hypertrophic Cardiomyopathy
|
N/A | |
Recruiting |
NCT04355260 -
The Clinical Research of the Safety and Effectiveness Evaluation for Using Echocardiography-guided Liwen RF Radiofrequency Ablation System to Treat Hypertrophic Obstructive Cardiomyopathy
|
N/A | |
Active, not recruiting |
NCT06003478 -
The Safety and Influencing Factors of Liwen Procedure in The Treatment of Hypertrophic Cardiomyopathy
|
||
Recruiting |
NCT05957419 -
Transapical Beating-Heart Septal Myectomy in Patient With Hypertrophic Obstructive Cardiomyopathy: a Multi-Center Study
|
N/A | |
Completed |
NCT04686487 -
SterEotactic AbLative Radiotherapy in PatiEnts With HypertrophiC ObstrucTive Cardiomyopathy
|
N/A | |
Completed |
NCT05671367 -
Association Between Microvascular Resistance and Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy
|
||
Completed |
NCT05687487 -
Residual or Recurrent Obstruction After Septal Myectomy
|
||
Enrolling by invitation |
NCT05100420 -
Hypertrophic Cardiomyopathy Registry, Biobank and Imaging Data Repository
|
||
Not yet recruiting |
NCT04275544 -
Risk Factors of Postoperative Complications in HCM Patients
|
||
Recruiting |
NCT06167876 -
Safety and Efficacy of Stereotactic Body Radiotherapy in the Treatment of Hypertrophic Obstructive Cardiomyopathy
|
N/A |